Abbott | Koszty Sprzedaży I Administracji



Selling And Administration Expenses Zmiana Data
Abbott USD 3.05B 144M 2025-03
Agilent USD 410M 16M 2025-01
AtriCure USD 76.05M 3.87M 2025-03
Baxter International USD 615M 16M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Bio-Rad Laboratories USD 199.7M 740K 2024-12
Boston Scientific USD 1.6B 15M 2025-03
Cooper Companies USD 387.9M 3.5M 2025-01
Danaher USD 1.86B 165M 2025-03
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 465.7M 26.2M 2025-03
Globus Medical USD 253.48M 12.74M 2024-12
Hologic USD 265M 15.8M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 563.4M 49.2M 2025-03
J&J USD 5.11B 1.34B 2025-03
Masimo USD 223.4M 38.6M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merit Medical Systems USD 107.49M 4.91M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Smith & Nephew USD 1.35B 12.8M 2024-12
Solventum Corp 784M 83M 2024-12
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 105.84M 6.2M 2024-12
Teleflex USD 254.55M 7.3M 2024-12
Terumo JPY 96.35B 3.76B 2024-12
Thermo Fisher Scientific USD 1.72B 487M 2025-03
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Abbott Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.